三维MR弹性成像可显示慢性乙型或丙型肝炎的肝脏炎症、纤维化及门脉高压
该前瞻性单中心研究纳入155例有肝活检的慢性乙型或丙型肝炎患者、85例有门脉高压并行HVPG测量者及60名健康志愿者,采用60Hz三维MR弹性成像测量多参数黏弹性。结果显示肝脏阻尼比与剪切硬度联合诊断坏死性炎症的AUC为0.88,且阻尼比和脾脏剪切硬度与HVPG独立相关。
要点
- 肝脏阻尼比在坏死性炎症患者中升高,可与纤维化F0期鉴别。
- 肝脏阻尼比联合剪切硬度诊断坏死性炎症及中重度活动度的AUC均为0.88。
- 肝脏阻尼比和脾脏剪切硬度与肝静脉压力梯度独立相关。
核心结论
- 三维MR弹性成像可能检测早期坏死性炎症、区分坏死性炎症与肝纤维化,并与慢性乙型或丙型肝炎患者的肝静脉压力梯度相关。
研究设计与样本
- 采用60Hz三维MR弹性成像测量剪切硬度、储能模量、损耗模量和阻尼比,以肝活检组织学评分和HVPG为参考标准,使用多变量逻辑或线性回归分析机械参数与组织学评分及HVPG的关联。
关键影像表现/征象
- 坏死性炎症患者肝脏阻尼比为0.13±0.03,高于无坏死性炎症(肝纤维化F0期)患者的0.10±0.02(P < .001)。
诊断标准与关键数值
- 在验证数据集中,肝脏阻尼比与剪切硬度联合诊断坏死性炎症的AUC为0.88(95% CI: 0.79, 0.96),评分中重度活动度的AUC为0.88(95% CI: 0.81, 0.95)。
- 肝脏阻尼比与HVPG独立相关(回归系数β = -30.3 [95% CI: -58.0, -2.5]; P = .03),脾脏剪切硬度亦与HVPG独立相关(β = 2.3 [95% CI: 1.7, 2.9]; P < .001)。
临床应用与阅片要点
- 在慢性乙型或丙型肝炎患者中,可关注肝脏阻尼比升高提示坏死性炎症,联合剪切硬度有助于无创评估炎症活动度。
- 脾脏剪切硬度和肝脏阻尼比可作为门脉高压严重程度的无创影像标志物,辅助HVPG评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The value of measuring mechanical properties to categorize various pathophysiologic states of the liver is as yet undetermined in chronic hepatitis B (CHB) or C (CHC). Purpose To evaluate multiparametric three-dimensional (3D) MR elastography as a means of detecting early necroinflammation, distinguishing necroinflammation from fibrosis, and gauging the severity of portal hypertension (PH) in CHB or CHC. Materials and Methods From January 2015 to September 2019, participants with CHB or CHC were prospectively enrolled from a single institution and were divided into two groups: those with liver biopsy and no evidence of PH (group 1) and those with PH and a hepatic venous pressure gradient (HVPG) measurement (group 2). For group 3, healthy volunteers were separately recruited from a nearby community. Multiple viscoelastic parameters (shear stiffness [SS], storage modulus, loss modulus, and damping ratio [DR]) were determined at 3D MR elastography at 60 Hz, and multivariable logistic or linear regression analysis was used to assess associations of mechanical parameters with histologic scores and HVPG. Results A total of 155 participants (median age, 41 years [interquartile range, 32-48 years]; 85 women) were in group 1 (training set: n = 78, validation set: n = 77), 85 participants (median age, 57 years [interquartile range, 43-61 years]; 51 women) in group 2, and 60 healthy volunteers (median age, 49 years [interquartile range, 27-64 years]; 38 men) in group 3. The liver DR was higher in participants with necroinflammation (DR, 0.13 ± 0.03) versus those without (at liver fibrosis stage F0) (DR, 0.10 ± 0.02; P < .001). Liver DR and SS together performed well in the diagnosis of necroinflammation (area under the receiver operating characteristic curve [AUC], 0.88 [95% CI: 0.79, 0.96]) and the scoring of moderate to severe activity (AUC, 0.88 [95% CI: 0.81, 0.95]) in the validation data set. Liver DR (regression coefficient [β] = -30.3 [95% CI: -58.0, -2.5]; P = .03) and splenic SS (β = 2.3 [95% CI: 1.7, 2.9]; P < .001) were independently associated with HVPG. Conclusion Three-dimensional MR elastography may detect early necroinflammation, distinguish necroinflammation from liver fibrosis, and correlate with hepatic venous pressure gradient in chronic hepatitis B and C. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Reeder in this issue.
引用
- Shi Y, Qi YF, Lan GY, et al. Three-dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C. Radiology. 2021. PMID: 34374594. doi:10.1148/radiol.2021202804
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。